共 5 条
[5]
Role of Anti-angiogenesis Agents in Treating NSCLC: Focus on Bevacizumab and VEGFR Tyrosine Kinase Inhibitors[J] . Elwyn Cabebe,Heather Wakelee.Current Treatment Options in Oncology . 2007 (1)